Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAMIS: Tirofiban Combined With Aspirin in Moderate Ischemic Stroke
NCT07760922Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of tirofiban in ischemic stroke, sponsored by Xinqiao Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07760922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07760922.